Dendreon Corp., of Seattle, reached an agreement with Valeant Pharmaceuticals International Inc., of Laval, Quebec, pursuant to which, subject to bankruptcy court approval, Valeant will serve as the "stalking horse" bidder in conjunction with a court-supervised sales process.